 The European Union has launched a new lawsuit against AstraZeneca that could lead to financial sanctions for the company, which the EU alleges has breached a supply contract for COVID-19 vaccines. The EU has opened a new front in its battle with AstraZeneca. Brussels on Tuesday launched a new lawsuit against the drugmaker, saying it had breached commitments on the supply of vaccines. That follows another case launched in late April. AstraZeneca has said the first case is without merit, saying it complied with all contractual requirements. It said the second case was unnecessary, given that one was already underway. On Tuesday, the EU's lawyer asked that AstraZeneca deliver 120 million shots by the end of June. A lawyer for the Anglo-Swedish firm said it was aiming for 100 million by that date. He says it has no obligation to supply more, as the original contract only required the firm to make its best reasonable efforts to supply a target of 300 million. AstraZeneca has blamed production problems and export restrictions for the delay in shipments.